- Reversible Dysphasia and Statins
-
Davies GR
- KMID: 2157911
- J Korean Med Sci.
- 2012 Apr;27(4):458-459.
- doi: 10.3346/jkms.2012.27.4.458
This paper presents a case of reversible dysphasia occurring in a patient prescribed atorvastatin in combination with indapamide. A milder dysphasia recurred with the prescription of rosuvastatin and was documented... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effects of Etodolac, Nimesulid and Naproxen Sodium on the Frequency of Sister Chromatid Exchange after Enclused Third Molars Surgery
-
Koseoglu B, Ozturk S, Kocak H, Palanduz S, Cefle K
- KMID: 2158192
- Yonsei Med J.
- 2008 Oct;49(5):742-747.
- doi: 10.3349/ymj.2008.49.5.742
PURPOSE: Non-steroidal anti-inflammatory drugs (NSAID) are frequently used in oral surgical procedures in dentistry. The evaluation of the frequency of sister chromatid exchange (SCE) is accepted as a reliable cytogenetic... -
- CITED
-
- Close
- SHARE
-
- Close
- Systematic Review and Meta-Analysis of Pulmonary Hypertension Specific Therapy for Exercise Capacity in Chronic Obstructive Pulmonary Disease
-
Park J, Song JH, Park DA, Lee JS, Lee SD, Oh YM
- KMID: 1793026
- J Korean Med Sci.
- 2013 Aug;28(8):1200-1206.
- doi: 10.3346/jkms.2013.28.8.1200
Some patients with chronic obstructive pulmonary disease (COPD) have pulmonary hypertension (PH) that adversely affects survival. We performed a systematic review and meta-analysis to assess whether PH-specific therapies have an... -
- CITED
-
- Close
- SHARE
-
- Close
- Meta-analysis of randomized controlled trials of bosentan for treatment of pulmonary arterial hypertension
-
Lee YH, Song GG
- KMID: 1780131
- Korean J Intern Med.
- 2013 Nov;28(6):701-707.
- doi: 10.3904/kjim.2013.28.6.701
BACKGROUND/AIMS: We assessed the efficacy and safety of bosentan in patients with pulmonary arterial hypertension (PAH). METHODS: We surveyed randomized controlled trials (RCTs) of the efficacy and safety of bosentan in... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study
-
Cho BW, Kim SB, Song IH, Lee SH, Kim HS, Lee TH, Kang YW, Kim SH, Lee BS, Chae HB
- KMID: 2412114
- Clin Mol Hepatol.
- 2017 Mar;23(1):51-56.
- doi: 10.3350/cmh.2016.0053
BACKGROUND/AIMS: The combination of daclatasvir (DCV) and asunaprevir (ASV) has demonstrated a high sustained virologic response at 12 weeks (SVR12) and a low rate of adverse events in previous clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Tamsulosin for the Treatment of Non-neurogenic Voiding Dysfunction in Females: A 8-Week Prospective Study
-
Lee KS, Han DH, Lee YS, Choo MS, Yoo TK, Park HJ, Yoon H, Jeong H, Lee SJ, Kim H, Park WH
- KMID: 1713841
- J Korean Med Sci.
- 2010 Jan;25(1):117-122.
- doi: 10.3346/jkms.2010.25.1.117
We evaluated the therapeutic effects of tamsulosin for women with non-neurogenic voiding dysfunction. Women who had voiding dysfunctions for at least 3 months were included. Inclusion criteria were age >... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of Short Term Clinical Effects and Presumptive Mechanism of Botulinum Toxin Type A as a Treatment Modality of Benign Prostatic Hyperplasia
-
Park DS, Cho TW, Lee YK, Lee YT, Hong YK, Jang WK
- KMID: 1381252
- Yonsei Med J.
- 2006 Oct;47(5):706-714.
- doi: 10.3349/ymj.2006.47.5.706
The purpose of this study was to evaluate the effect and investigate the putative mechanism of botulinum toxin type A (BTA) applied to the treatment of benign prostatic hyperplasia (BPH).... -
- CITED
-
- Close
- SHARE
-
- Close
- A Randomized, Multicenter, Phase III Trial to Evaluate the Efficacy and Safety of Polmacoxib Compared with Celecoxib and Placebo for Patients with Osteoarthritis
-
Lee M, Yoo J, Kim JG, Kyung HS, Bin SI, Kang SB, Choi CH, Moon YW, Kim YM, Han SB, In Y, Choi CH, Kim J, Lee BK, Cho S
- KMID: 2412245
- Clin Orthop Surg.
- 2017 Dec;9(4):439-457.
- doi: 10.4055/cios.2017.9.4.439
BACKGROUND: The aim of this study was to evaluate the safety and analgesic efficacy of polmacoxib 2 mg versus placebo in a superiority comparison or versus celecoxib 200 mg in... -
- CITED
-
- Close
- SHARE
-
- Close
